Assignee profile:

SpinalCyte, LLC

City:

Houston, Texas

Country:

United States

Published Applications:

25

Last publication date:

2026-04-30

Patent Grants:

20

Last grant date:

2025-09-02

Top Inventors for applications by SpinalCyte, LLC

These are the the leading inventors for applications assigned to SpinalCyte, LLC:

Recent patent applications by SpinalCyte, LLC

SpinalCyte, LLC based in Houston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-30
US20260117185A1
Chemistry; metallurgy

ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION

#2 | 2025-05-08
US20250144151A1
Human necessities

INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR ACTIVATION AND USES THEREOF

#3 | 2025-02-06
US20250041352A1
Human necessities

TREATMENT OF OPIOID ADDICTION USING FIBROBLASTS AND PRODUCTS THEREOF

#4 | 2025-02-06
US20250041351A1
Human necessities

FIBROBLAST THERAPY FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

#5 | 2023-06-01 ✅ Patent 12,404,494 granted on 2025-09-02
US20230167410A1
Chemistry; metallurgy

PREVENTION OF RECURRENT MISCARRIAGES THROUGH ADMINISTRATION OF FIBROBLASTS AND FIBROBLAST-EDUCATED PATERNAL CELLS

#6 | 2023-03-30 ✅ Patent 12,508,287 granted on 2025-12-30
US20230098890A1
Human necessities

TREATMENT OF CEREBRAL PALSY USING FIBROBLASTS

#7 | 2023-01-26 ✅ Patent 12,576,112 granted on 2026-03-17
US20230023269A1
Human necessities

INHIBITION OF TNF-ALPHA BY FIBROBLASTS AND FIBROBLAST EXOSOMES

#8 | 2022-11-24 ✅ Patent 12,544,408 granted on 2026-02-10
US20220370505A1
Human necessities

PREVENTION AND TREATMENT OF KIDNEY FAILURE BY ADMINISTRATION OF FIBROBLASTS AND PRODUCTS THEREOF

#9 | 2022-10-27 ✅ Patent 12,648,968 granted on 2026-06-09
US20220339201A1
Human necessities

FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE

#10 | 2021-12-23 ✅ Patent 12,233,094 granted on 2025-02-25
US20210393700A1
Human necessities

Interaction of fibroblasts and immune cells for activation and uses thereof

#11 | 2020-12-03 ✅ Patent 12,090,174 granted on 2024-09-17
US20200376042A1
Human necessities

Fibroblast therapy for treatment of Duchenne muscular dystrophy

#12 | 2020-09-24 ✅ Patent 12,133,870 granted on 2024-11-05
US20200297773A1
Human necessities

Treatment of opioid addiction using fibroblasts and products thereof

#13 | 2020-08-20 ✅ Patent 11,717,596 granted on 2023-08-08
US20200261620A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#14 | 2019-01-24
US20190022145A1
Human necessities

CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS

#15 | 2018-11-08 ✅ Patent 10,806,824 granted on 2020-10-20
US20180318466A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#16 | 2018-07-12 ✅ Patent 11,034,934 granted on 2021-06-15
US20180195044A1
Chemistry; metallurgy

Methods of enhancing fibroblast therapeutic activity

#17 | 2017-03-30 ✅ Patent 10,052,410 granted on 2018-08-21
US20170087277A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#18 | 2014-12-25 ✅ Patent 10,206,954 granted on 2019-02-19
US20140377231A1
Human necessities

Adipose cells for chondrocyte applications

#19 | 2011-11-10 ✅ Patent 9,138,460 granted on 2015-09-22
US20110275151A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#20 | 2010-11-11 ✅ Patent 9,533,024 granted on 2017-01-03
US20100285093A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#21 | 2010-11-11 ✅ Patent 9,320,776 granted on 2016-04-26
US20100285092A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#22 | 2010-11-11 ✅ Patent 8,728,495 granted on 2014-05-20
US20100285091A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#23 | 2010-11-11 ✅ Patent 8,298,560 granted on 2012-10-30
US20100285090A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#24 | 2010-08-26 ✅ Patent 9,545,432 granted on 2017-01-17
US20100216210A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

#25 | 2007-08-09 ✅ Patent 7,850,983 granted on 2010-12-14
US20070184033A1
Human necessities

Methods and compositions for repair of cartilage using an in vivo bioreactor

Also check out SpinalCyte, LLC's (Houston, United States) applicant profile with 20 patent applications submitted.

AssigneeID:

144321 ⎘